marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q2
added 08-14-2024
Cara Therapeutics Cash Flow 2011-2024 | CARA
Annual Cash Flow Cara Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-92.1 M | -78.7 M | -60.1 M | -5.49 M | -109 M | -22.3 M | -54.8 M | -47.4 M | - | - | - | - | - |
Depreciation & Amortization |
259 K | 248 K | 248 K | 209 K | 198 K | 370 K | 495 K | 1.46 M | 839 K | 783 K | 789 K | 1.02 M | - |
Accounts Payables |
11.6 M | 9.6 M | 5.62 M | 4.89 M | 9.1 M | 4.37 M | 3.83 M | 4.74 M | 1.96 M | 515 K | - | - | - |
Accounts Receivables |
2.76 M | 3.26 M | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
2.82 M | 2.38 M | 2.58 M | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Cara Therapeutics
| 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | -30.5 M | - | - | - | -34.6 M | - | -55.2 M | -30 M | -25.5 M | - | -58.8 M | -44.7 M | -23.7 M | - | -87.6 M | -66 M | -38.3 M | - | -78.1 M | -52.4 M | -27.5 M | - | 2.06 M | 22.6 M | -18.5 M | - | -43.4 M | -33.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Depreciation & Amortization |
- | 42 K | - | - | - | 58 K | - | 187 K | 126 K | 63 K | - | 186 K | 124 K | 63 K | - | 147 K | 96 K | 48 K | - | 150 K | 100 K | 50 K | - | 318 K | 239 K | 125 K | - | 370 K | 245 K | 122 K | - | 1.35 M | 1.25 M | 730 K | - | 580 K | 386 K | 193 K | - | 590 K | 393 K | 197 K | - | 592 K | 395 K | 198 K | - | - | - | - | - | - | - | - |
Accounts Payables |
6.76 M | 4.98 M | 11.6 M | 7.98 M | 12.1 M | 4.42 M | 9.6 M | 15.2 M | 9.74 M | 5.59 M | 5.62 M | 5.37 M | 3.39 M | 4.76 M | 4.89 M | 4.89 M | 4.89 M | 4.89 M | 9.1 M | 9.1 M | 9.1 M | 9.1 M | 4.37 M | 4.37 M | 4.37 M | 4.37 M | 3.83 M | 3.83 M | 3.83 M | 3.83 M | 4.74 M | 4.74 M | 4.74 M | 4.74 M | 1.96 M | 1.96 M | 1.96 M | 1.96 M | 515 K | 515 K | 515 K | 515 K | 676 K | 676 K | 676 K | 676 K | - | - | - | - | - | - | - | - |
Accounts Receivables |
359 K | 1.72 M | 2.76 M | 3.35 M | - | - | 3.26 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 80 K | - | - | - | - | - | 480 K | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
1.64 M | 2.74 M | 2.82 M | 3.27 M | 3.42 M | 3.52 M | 2.38 M | 1.84 M | 3.46 M | 1.91 M | 2.58 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency